Clinical Trial Update: MSC Administration for the Management of Type 1 Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mesenchymal stem cell therapy for Type 1 Diabetes Mellitus. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Universidad del Desarrollo | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: UNKNOWN